טוען...
Disclosing genetic risk for Alzheimer's dementia to individuals with mild cognitive impairment
INTRODUCTION: The safety of predicting conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) dementia using apolipoprotein E (APOE) genotyping is unknown. METHODS: We randomized 114 individuals with MCI to receive estimates of 3‐year risk of conversion to AD dementia infor...
שמור ב:
| הוצא לאור ב: | Alzheimers Dement (N Y) |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7087414/ https://ncbi.nlm.nih.gov/pubmed/32211507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/trc2.12002 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|